Entheon Biomedical Corp.: Entheon to Participate in the H.C. Wainwright 2nd Annual Psychedelics Conference on December 6, 2021

Vancouver, British Columbia--(Newsfile Corp. - December 3, 2021) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) ("Entheon" or the "Company"), a biomedical company focused on the research

Related Keywords

United States ,Canada ,United Kingdom ,Bluesky ,Alberta ,Vancouver ,British Columbia ,British ,Timothy Ko ,Joseph Cullen ,Elizabeth Glassen ,European Union ,Entheon Biomedical Corp ,Bluesky Communications ,British Columbia Newsfile Corp ,Chief Executive Officer ,Psychedelics Conference ,Entheon ,Iomedical ,Orp ,Articipate ,Wainwright ,Nnual ,Psychedelics ,Conference ,December ,021 ,